Autophagy, Inflammation, and Metabolism (AIM) Center in its second year

BURGE, MARK; LIU, KE JIAN; SKLAR, LARRY A.; GARCIA, SALLY ANN; BEHRENDS, CHRISTIAN; CHEN, GUANG-CHAO; FOURIE, BERNARD; JO, EUN-KYEONG; KIMCHI, ADI; MIZUSHIMA, NOBORU; RUBINSZTEIN, DAVID; SHEN, HAN-MIN; VACCARO, MARIA; ZHANG, HONG; PROSSNITZ, ERIC; CANNON, JUDY; HALL, PAMELA; MARISCAL, LUISA; BAEHRECKE, ERIC H.; CODOGNO, PATRICE; ESKELINEN, EEVA-LIISA; HONG, WANJIN; JUHÁSZ, GÁBOR; KROEMER, GUIDO; REGGIORI, FULVIO; SCHRODER, KATE; TOOZE, SHARON A.; YU, LI; DERETIC, VOJO; CAMPEN, MATTHEW J.; LIU, MEILIAN; ALLERS, LEE; WEAVER, JOHN; CECCONI, FRANCESCO; ELAZAR, ZVULUN; GOZUACIK, DEVRIM; JOHANSEN, TERJE; KTISTAKIS, NICHOLAS; MÜNZ, CHRISTIAN; RYAN, KEVIN; SIMONSEN, ANNE; YOSHIMORI, TAMOTSU; KLIONSKY, DANIEL J.

AUTOPHAGY

LANDES BIOSCIENCE

Año: 2019 vol. 15 p. 1829 - 1833

1554-8627

Autophagy, Inflammation, and Metabolism (AIM) Center in its second yearVojo Deretic a, Eric Prossnitza, Mark Burgea, Matthew J. Campena, Judy Cannona, Ke Jian Liua, Meilian Liua,Pamela Halla, Larry A. Sklara, Lee Allersa, Luisa Mariscala, Sally Ann Garciaa, John Weavera, Eric H. Baehreckeb,Christian Behrendsc, Francesco Cecconid, Patrice Codognoe, Guang-Chao Chenf, Zvulun Elazarg, Eeva-Liisa Eskelinenh,Bernard Fouriei, Devrim Gozuacikj, Wanjin Hongk, Eun-Kyeong Jol, Terje Johansenm, Gábor Juhászn, Adi Kimchio,Nicholas Ktistakis p, Guido Kroemerq,r,s,t,u, Noboru Mizushimav, Christian Münzw, Fulvio Reggiorix, David Rubinszteiny,Kevin Ryanz, Kate Schroderaa, Han-Min Shenbb, Anne Simonsencc, Sharon A. Toozedd, Maria Vaccaroee,Tamotsu Yoshimoriff, Li Yugg, Hong Zhanghh, and Daniel J. Klionskyii ABSTRACTThe NIH-funded center for autophagy research named Autophagy, Inflammation, and Metabolism(AIM) Center of Biomedical Research Excellence, located at the University of New Mexico HealthScience Center is now completing its second year as a working center with a mission to promoteautophagy research locally, nationally, and internationally. The center has thus far supported a cadreof 6 junior faculty (mentored PIs; mPIs) at a near-R01 level of funding. Two mPIs have graduated byobtaining their independent R01 funding and 3 of the remaining 4 have won significant fundingfrom NIH in the form of R21 and R56 awards. The first year and a half of setting up the center hasbeen punctuated by completion of renovations and acquisition and upgrades for equipment sup-porting autophagy, inflammation and metabolism studies. The scientific cores usage, and the growthof new studies is promoted through pilot grants and several types of enablement initiatives. Theintent to cultivate AIM as a scholarly hub for autophagy and related studies is manifested in itsVibrant Campus Initiative, and the Tuesday AIM Seminar series, as well as by hosting a major scientificevent, the 2019 AIM symposium, with nearly one third of the faculty from the International Council ofAffiliate Members being present and leading sessions, giving talks, and conducting workshopactivities. These and other events are often videostreamed for a worldwide scientific audience, andinformation about events at AIM and elsewhere are disseminated on Twitter and can be followed onthe AIM web site. AIM intends to invigorate research on overlapping areas between autophagy,inflammation and metabolism with a number of new initiatives to promote metabolomic research.With the turnover of mPIs as they obtain their independent funding, new junior faculty are recruitedand appointed as mPIs. All these activities are in keeping with AIM?s intention to enable the nextgeneration of autophagy researchers and help anchor, disseminate, and convey the depth andexcitement of the autophagy field.a